Ajjai S Alva
Maisel Research Professor of Translational/Clinical Oncology
Clinical Professor of Internal Medicine
[email protected]

Available to mentor
Ajjai S Alva
Clinical Professor
  • About
  • Qualifications
  • Center Memberships
  • Recent Publications
    • About

    Maisel Research Professor of Clinical and Translational Oncology
    Clinical Professor, Division of Hematology Oncology, Department of Internal Medicine
    Steering Committee Member, ORP NCCN
    University of Michigan Rogel Comprehensive Cancer Center

    Qualifications
    • MS Cell Biology Molecular Genetics
      University of Maryland, College Park, College Park, 2004
    • MB BS
      Jawaharlal Institute of Postgraduate Medical Education and Research, Dhanvantari Nagar, 2000
    • FASCO
      American Society of Clinical Oncology, Alexandria
    Center Memberships
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043.
      Zakharia Y, Singer EA, Acharyya S, Garje R, Joshi M, Peace D, Baladandayuthapani V, Majumdar A, Li X, Lalancette C, Kryczek I, Zou W, Alva A. Nat Commun, 2024 Feb 1; 15 (1): 972 DOI:10.1038/s41467-024-45216-z
      PMID: 38302476
    • Journal Article
      Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.
      Orme JJ, Taza F, De Sarkar N, Tewari AK, Arsalan Naqvi S, Riaz IB, Childs DS, Omar N, Adra N, Ashkar R, Cheng HH, Schweizer MT, Sokolova AO, Agarwal N, Barata P, Sartor O, Bastos D, Smaletz O, Berchuck JE, McClure H, Taplin M-E, Aggarwal R, Sternberg CN, Vlachostergios PJ, Alva AS, Mehra N, Nelson PS, Hwang J, Dehm SM, Shi Q, Fleischmann Z, Sokol ES, Elliott A, Huang H, Bryce A, Marshall CH, Antonarakis ES. Eur Urol Oncol, 2024 Aug; 7 (4): 877 - 887. DOI:10.1016/j.euo.2023.11.014
      PMID: 38072760
    • Journal Article
      Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients.
      Wang Y, Abu-Sbeih H, Tang T, Shatila M, Faleck D, Harris J, Dougan M, Olsson-Brown A, Johnson DB, Shi C, Grivas P, Diamantopoulos L, Owen DH, Cassol C, Arnold CA, Warner DE, Alva A, Powell N, Ibraheim H, De Toni EN, Philipp AB, Philpott J, Sleiman J, Lythgoe M, Daniels E, Sandhu S, Weppler AM, Buckle A, Pinato DJ, Thomas A, Qiao W. Gastrointest Endosc, 2024 Aug; 100 (2): 273 - 282.e4. DOI:10.1016/j.gie.2024.01.024
      PMID: 38272276
    • Journal Article
      Outcome Prediction Using Multi-Modal Information: Integrating Large Language Model-Extracted Clinical Information and Image Analysis.
      Sun D, Hadjiiski L, Gormley J, Chan H-P, Caoili E, Cohan R, Alva A, Bruno G, Mihalcea R, Zhou C, Gulani V. Cancers (Basel), 2024 Jun 29; 16 (13): DOI:10.3390/cancers16132402
      PMID: 39001463
    • Journal Article
      A multi-institutional observer study of AI-aided oncologists' performance on treatment response assessment of bladder cancer.
      Sun D, Alva AS, Palmbos P, Zakharia Y, Garje R, Chan H-P, Cohan RH, Hadjiiski L. Journal of Clinical Oncology, 2024 Jun 1; 42 (16_suppl): 4599 - 4599. DOI:10.1200/jco.2024.42.16_suppl.4599
    • Journal Article
      Association of tumor genetics with outcomes in patients (pts) with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) treated with 177Lu-PSMA-617.
      Panian J, Henderson N, Barata PC, Bilen MA, Graham L, Heath EI, Herchenhorn D, Hwang C, Kilari D, Koshkin VS, Nauseef JT, Sokolova A, Zakharia Y, Schweizer MT, Dorff TB, Armstrong AJ, Alva AS, McKay RR. Journal of Clinical Oncology, 2024 Jun 1; 42 (16_suppl): 5050 - 5050. DOI:10.1200/jco.2024.42.16_suppl.5050
    • Journal Article
      Efficacy of erdafitinib in FGFR2/3-altered metastatic urothelial cancer including patients with CDK2NA/B or MTAP loss: Analysis of UNITE study.
      Jiang CY, Jindal T, Epstein IB, Nguyen CB, Nizam A, Bakaloudi DR, Taylor AK, Milowsky MI, Shah S, Hoimes CJ, Bilen MA, Zakharia Y, Emamekhoo H, Grivas P, Gupta S, Bellmunt J, Alva AS, Koshkin VS, Alhalabi O, Campbell MT. Journal of Clinical Oncology, 2024 Jun 1; 42 (16_suppl): e16571 - e16571. DOI:10.1200/jco.2024.42.16_suppl.e16571
    • Journal Article
      First-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma (RCC): An international multi-center study.
      El Zarif T, Semaan K, Xie W, Nguyen CB, Fahey C, Zarba M, Zemankova A, Ebrahimi H, Procopio G, Stellato M, Buti S, Melichar B, Venugopal B, Karam JA, Campbell MT, Beckermann K, Alva AS, Pal SK, Heng DYC, CHOUEIRI TK. Journal of Clinical Oncology, 2024 Jun 1; 42 (16_suppl): 4529 - 4529. DOI:10.1200/jco.2024.42.16_suppl.4529